Investing in Adult Stem Cell Research
A CNN Money article from August talked about how biotech companies working with adult stem cells are getting closer to producing treatments. The article mentions three companies in particular:
- ASTM (Aastrom Biosciences, Inc.) -- working on treatment to regrow bone tissue
- OSIR (Osiris Therapeutics) -- IPO'd on Aug 4. Just began Phase 3 trials for Prochymal for treatment of Acute Graft vs. Host disease, and Phase 2 trials (also Prochymal) for Crohn's disease.
- CYTX (Cytori Therapeutics, Inc.) -- working on using patient's adipose tissue for breast reconstruction